Journal article
Diagnostic measures for sarcopenia and bone mineral density
AY Bijlsma, MCG Meskers, M Molendijk, RGJ Westendorp, S Sipilä, L Stenroth, E Sillanpää, JS McPhee, DA Jones, M Narici, H Gapeyeva, M Pääsuke, E Seppet, T Voit, Y Barnouin, JY Hogrel, G Butler-Browne, AB Maier
Osteoporosis International | SPRINGER LONDON LTD | Published : 2013
Abstract
Currently used diagnostic measures for sarcopenia utilize different measures of muscle mass, muscle strength, and physical performance. These diagnostic measures associate differently to bone mineral density (BMD), as an example of muscle-related clinical outcome. These differences should be taken into account when studying sarcopenia. Introduction: Diagnostic measures for sarcopenia utilize different measures of muscle mass, muscle strength, and physical performance. To understand differences between these measures, we determined the association with respect to whole body BMD, as an example of muscle-related clinical outcome. Methods: In the European cross-sectional study MYOAGE, 178 young ..
View full abstractGrants
Awarded by Institut National de la Santé et de la Recherche Médicale
Funding Acknowledgements
This study was supported by an unrestricted grant from the seventh framework program MYOAGE (HEALTH-2007-2.4.5-10), 050-060-810 The Netherlands Consortium for Healthy Aging (NCHA)), Estonian Science Foundation (grants # 8736 and # 7823), the Estonian Ministry of Education and Research (grant SF01080114As08), and the Association Francais contres les Myopathies (AFM), Inserm, Universite Pierre et Marie Curie (UPMC), the CNRS. The authors thank M. van der Bij, T. M. Maden-Wilkinson, and Dr. I. Kull for support, and E. Klaus; Dr. J. Ereline; Dr. T. Kums, MSc; H Aibast; and C Levergeois for their skillful technical assistance.